Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to -$500000.0.

  • Myriad Genetics' Change in Taxes rose 6153.85% to -$500000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year decrease of 70000.0%. This contributed to the annual value of -$500000.0 for FY2024, which is 2857.14% up from last year.
  • Myriad Genetics' Change in Taxes amounted to -$500000.0 in Q3 2025, which was up 6153.85% from -$2.1 million recorded in Q1 2025.
  • In the past 5 years, Myriad Genetics' Change in Taxes ranged from a high of $18.1 million in Q4 2021 and a low of -$90.3 million during Q1 2021
  • Over the past 5 years, Myriad Genetics' median Change in Taxes value was -$400000.0 (recorded in 2023), while the average stood at -$5.9 million.
  • Data for Myriad Genetics' Change in Taxes shows a peak YoY increase of 10202.43% (in 2021) and a maximum YoY decrease of 1300000.0% (in 2021) over the last 5 years.
  • Myriad Genetics' Change in Taxes (Quarter) stood at $18.1 million in 2021, then plummeted by 101.1% to -$200000.0 in 2022, then plummeted by 150.0% to -$500000.0 in 2023, then dropped by 20.0% to -$600000.0 in 2024, then grew by 16.67% to -$500000.0 in 2025.
  • Its Change in Taxes was -$500000.0 in Q3 2025, compared to -$2.1 million in Q1 2025 and -$600000.0 in Q4 2024.